Multiple studies have demonstrated the ability of urate-lowering therapy to reduce or resolve tophi in patients with gout. Now, researchers sought to determine how quickly a certain drug could resolve the...
The FDA has called for the addition of a Boxed Warning alerting clinicians and patients of an increased risk of cardiovascular death with the use of a drug used for the treatment of gout.
The FDA has called for the addition of a Boxed Warning alerting clinicians and patients of an increased risk of cardiovascular death with the use of a drug used for the treatment of gout.
In a recent study, researchers investigated whether the use of a drug used to treat gout and kidney stones could affect the risk of developing chronic kidney disease.
In an analysis of more than 10,000 adults who experienced a prior heart attack, researchers compared efficacy of canakinumab vs placebo for preventing gout attacks.
Previous studies on fracture risk among gout patients have yielded conflicting results. In a new study, researchers aimed to further clarify the potential relationship between gout and fractures, as well as...
Patients with gout are known to have an increased risk of cardiovascular disease. In a recent study, researchers compared the effects of probenecid vs allopurinol on this risk.
After clinical trials demonstrated its safety and efficacy, the FDA approved a new treatment that is the first to combine standard care with a new therapy for adult patients with hyperuricemia associated...
In a recent study, researchers evaluated how the risk of nephrolithiasis is affected by a gout diagnosis, comorbidities, medication use, and other factors. To see results of the study, including which...
Previous research has suggested that patients with gout have a reduced risk for infections due to the pro-inflammatory state caused by the disease. In a new study, researchers compared incidents of urinary...
